PKU HealthCare Corp.,Ltd. (SHE:000788)

Market Cap	3.54B
Revenue (ttm)	2.07B
Net Income (ttm)	139.59M
Shares Out	595.99M
EPS (ttm)	0.23
PE Ratio	25.36
Forward PE	n/a
Dividend	0.06 (1.01%)
Ex-Dividend Date	n/a

Volume	9,160,300
Average Volume	8,400,727
Open	5.83
Previous Close	5.94
Day's Range	5.83 - 6.04
52-Week Range	4.82 - 7.48
Beta	0.29
RSI	59.11
Earnings Date	May 26, 2025

About PKU HealthCare Corp.,Ltd.

PKU HealthCare Corp.,Ltd. researches, develops, manufactures, and sells pharmaceutical products in China. It offers products in various categories, including anti-tumor, psychoneurological, cardiovascular, immunosuppressive, antimicrobial, antipyretic and analgesic, digestive system, regulate immunity, oncology, anti-allergic, blood sugar regulation, mental disorder, and blood volume expansion. The company was formerly known as PUK International Hospital Group Southwest Synthetic Pharmaceutical Corp., Ltd. and changed its name to PKU HealthCare...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1965
• Employees: 772
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000788

Financial Performance

In 2024, PKU HealthCare Corp.,Ltd.'s revenue was 2.06 billion, a decrease of -6.10% compared to the previous year's 2.19 billion. Earnings were 137.99 million, an increase of 211.10%.